Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lang

Showing results (181-190 of 205) with videos related to

Pageof 21
Sort By:
Deutsche Medizinische Wochenschrift (1946)|August 2, 2014
[Chronic thromboembolic pulmonary hypertension--a position paper]H Wilkens, I Lang, T Blankenburg, et al.
Deutsche Medizinische Wochenschrift (1946)|September 24, 2010
[Chronic thromboembolic pulmonary hypertension: recommendations of the Cologne Consensus Conference 2010]H Wilkens, I Lang, J Behr, et al.
Clinical Pharmacology and Therapeutics|April 27, 2017
Population Pharmacokinetics of Liposomal Irinotecan in Patients With CancerB S Adiwijaya, J Kim, I Lang, et al.
British Journal of Cancer|October 1, 2014
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analysesT Brodowicz, I Lang, Z Kahan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2016
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)G Jerusalem, G Mariani, E M Ciruelos, et al.
Nano Letters|April 26, 2021
Oleylamine Aging of PtNi Nanoparticles Giving Enhanced Functionality for the Oxygen Reduction ReactionGerard M Leteba, Yi-Chi Wang, Thomas J A Slater, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 11, 2012
Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysisC Matuschek, E Bölke, S L Roth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2007
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015C-H Köhne, J De Greve, J T Hartmann, et al.
Journal of Thermal Biology|August 17, 2024
The effects and mechanisms of heat stress on mammalian oocyte and embryo developmentL I Lang, Zhen-Zhen Wang, Bin Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2006
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005E Van Cutsem, M Dicato, N Arber, et al.
Pageof 21

Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
Deutsche Medizinische Wochenschrift (1946)|August 2, 2014
[Chronic thromboembolic pulmonary hypertension--a position paper]H Wilkens, I Lang, T Blankenburg, et al.
Deutsche Medizinische Wochenschrift (1946)|September 24, 2010
[Chronic thromboembolic pulmonary hypertension: recommendations of the Cologne Consensus Conference 2010]H Wilkens, I Lang, J Behr, et al.
Clinical Pharmacology and Therapeutics|April 27, 2017
Population Pharmacokinetics of Liposomal Irinotecan in Patients With CancerB S Adiwijaya, J Kim, I Lang, et al.
British Journal of Cancer|October 1, 2014
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analysesT Brodowicz, I Lang, Z Kahan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2016
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)G Jerusalem, G Mariani, E M Ciruelos, et al.
Nano Letters|April 26, 2021
Oleylamine Aging of PtNi Nanoparticles Giving Enhanced Functionality for the Oxygen Reduction ReactionGerard M Leteba, Yi-Chi Wang, Thomas J A Slater, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 11, 2012
Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysisC Matuschek, E Bölke, S L Roth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2007
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015C-H Köhne, J De Greve, J T Hartmann, et al.
Journal of Thermal Biology|August 17, 2024
The effects and mechanisms of heat stress on mammalian oocyte and embryo developmentL I Lang, Zhen-Zhen Wang, Bin Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2006
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005E Van Cutsem, M Dicato, N Arber, et al.
Pageof 21